U-Blot® Dostarlimab Polyclonal AntibodyCat. No. WP26401Request quote
Size: 50μL/100μL
Polyclonal antibodies are produced from the serum of immunized animals and target multiple epitopes on antigens. They deliver robust binding signals, high experimental tolerance, short production cycles and excellent cost-effectiveness. They are ideal for preliminary target verification and short-term research applications.
U-Blot® Dostarlimab Polyclonal AntibodyCat. No. WP26401
U-Blot® Aducanumab Polyclonal AntibodyCat. No. WP26400
U-Blot® Evinacumab Polyclonal AntibodyCat. No. WP26399
U-Blot® Tralokinumab Polyclonal AntibodyCat. No. WP26398
U-Blot® Bimekizumab Polyclonal AntibodyCat. No. WP26397
U-Blot® Loncastuximab Polyclonal AntibodyCat. No. WP26396
U-Blot® Anifrolumab Polyclonal AntibodyCat. No. WP26395
U-Blot® Amivantamab Polyclonal AntibodyCat. No. WP26394
U-Blot® Tisotumab Polyclonal AntibodyCat. No. WP26393
U-Blot® Tezepelumab Polyclonal AntibodyCat. No. WP26392
U-Blot® Sutimlimab Polyclonal AntibodyCat. No. WP26391
U-Blot® Faricimab Polyclonal AntibodyCat. No. WP26390